Search - tctmd.com

Displaying 581 - 600 of 1184

Sort: Relevancy | Date

News Daily News

Majority of Short-term PCI Readmissions for Angina Concerns, not Complications

Jason Kahn

January 23, 2014

News Daily News

Bioresorbable Scaffold Performs Well in Select STEMI Patients

January 22, 2014

News Daily News

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

January 22, 2014

News Daily News

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Jason Kahn

January 15, 2014

News Daily News

Thrombectomy Shows Long-term, but no Short-term, Benefit in STEMI Patients

Jason Kahn

January 09, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Daily News

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

January 06, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Daily News

Los SLF de 2ª Generación son la Mejor Opción para Pacientes víctimas de STEMI

December 09, 2013

News Daily News

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

December 08, 2013

News Daily News

El Guiado mediante IVUS Reduce la Trombosis del STENT y los MACE comparado con la Angiografía

December 08, 2013

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

L.A. McKeown

November 01, 2013

News Conference News TCT 2013

Studies Find Differing Benefits of Platelet, Genotype Testing

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

Advertisement

Majority of Short-term PCI Readmissions for Angina Concerns, not Complications

Bioresorbable Scaffold Performs Well in Select STEMI Patients

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Thrombectomy Shows Long-term, but no Short-term, Benefit in STEMI Patients

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Second-Generation DES the Better Choice for STEMI Patients

Los SLF de 2ª Generación son la Mejor Opción para Pacientes víctimas de STEMI

IVUS Guidance Reduces Stent Thrombosis, MACE Compared to Angiography

El Guiado mediante IVUS Reduce la Trombosis del STENT y los MACE comparado con la Angiografía

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Findings Support DAPT Duration Longer Than 3 Months in ACS Patients

Studies Find Differing Benefits of Platelet, Genotype Testing

OPTIMIZE: 3-Month DAPT Safe with ZES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content